The stock code: 300723
The stock abbreviation: Yipinhong
Announcement number: 2026-030
Yipinhong Pharmaceutical Group Co., Ltd. announces that its wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has received acceptance of the clinical trial application for the innovative drug APH04935 tablets from the National Medical Products Administration, along with the "Acceptance Notice." The relevant details are as follows:
1. Main Content of the Acceptance Notice
| Drug Name | Application Matter | Indication | Acceptance Number |
|---|---|---|---|
| APH04935 Tablets | Domestic production drug registration clinical trial | Weight loss and long-term weight management for overweight or obese adults | CXHL2600660, CXHL2600661, CXHL2600662 |
According to Article 32 of the Administrative Licensing Law of the People's Republic of China, the application has been accepted after review.